Schematic model. In this model, OGs are activated either by damage to myelin (asterisks in red) or by endogenous deregulation, resulting in GF production and remyelination (lipogenic) growth responses. GFs from OGs trigger oligodendrocyte progenitor (OGP) cells to divide, but they also reach other cell types through extracellular space and perhaps through the myelin sheath into axons and adjacent OGs. Excess GFs from OGs trigger TS pathways specific to various brain cell types, which, in turn, induce unfavorable ECM changes by astroglia (A), proinflammatory cytokines (INF) from microglia (MG) and astroglia, and repression of protein synthesis (PS) in neurons (N). These TS responses impair axonal protein transport, induce axonal retraction, activate additional remyelination programs, and culminate in NFTs and, perhaps, altered amyloid precursor protein processing. This process begins in the entorhinal cortex and spreads sequentially through adjacent OGs (1-4) along myelinated axons to the hippocampus and neocortex.